Drugs firms Pfizer and Flynn broke law with 2,600% price increase for epilepsy tablets to NHS, UK watchdog finds

Two drugs firms have been accused by the UK’s competition watchdog of illegal pricing and abusing their dominant position to overcharge the NHS for vital anti-epilepsy tablets. The Competition and Markets Authority (CMA) said it had provisionally found that coronavirus